m.info.boehringer-ingelheim.ca
Open in
urlscan Pro
54.200.36.35
Public Scan
Submitted URL: http://senvelgosample.com/
Effective URL: https://m.info.boehringer-ingelheim.ca/webApp/bahUsSenvelgo?id=0
Submission: On December 02 via manual from DE — Scanned from DE
Effective URL: https://m.info.boehringer-ingelheim.ca/webApp/bahUsSenvelgo?id=0
Submission: On December 02 via manual from DE — Scanned from DE
Form analysis 1 forms found in the DOM
POST
<form data-it-registration-form-name="Senvelgo24 US" class="needs-validation sync-form" novalidate="" autocomplete="off" id="page-form" method="post">
<div class="scp-webpage-schema">
<div></div>
<div id="block16ab5787-bd35-4e0f-a6a5-df1a28e49229" class="block-wrapper">
<div>
<div class="container-fluid" style="padding-top: 60px; padding-bottom: 25px;">
<div class="container">
<div class="row gx-5">
<div class="col-md-12" allowmodifycontent="true">
<div incontentsection="innerContent"><img src="https://res.info.boehringer-ingelheim.ca/res/boehrin_mkt_prod1/dd0644078d185342c8c9bb4fefc01f50.png" alt="" width="200" class="img-fluid d-block mx-auto mobile-width-100 nlui-widget">
</div>
<div role="presentation" class="spacer" incontentsection="innerContent" style="height: 20px;"></div>
<div class="">
<h1>Get to know<br>SENVELGO<sup>®</sup> (velagliflozin oral solution)</h1>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div id="blocke6634158-59c3-4357-b0c4-fe6c57aee2e8" class="block-wrapper">
<div>
<div class="container-fluid">
<div class="container" style="padding-top: 20px; padding-bottom: 20px; max-width: 500px;">
<div class="row gx-5">
<div class="col-md-12" allowmodifycontent="true">
<div class="ratio ratio-16x9" incontentsection="innerContent"><iframe src="https://players.brightcove.net/4309680634001/default_default/index.html?videoId=6362111956112" allowfullscreen="allowfullscreen" allow="encrypted-media"
style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div>
</div>
</div>
</div>
</div>
<div style="height: 15px;" class=""></div>
</div>
</div>
<div id="blocke7e7801d-8193-43eb-8bc8-d730038a16c6" class="block-wrapper">
<div>
<div class="container-fluid">
<div class="container" style="padding-top: 15px; padding-bottom: 0px;">
<div class="row gx-5">
<div class="col-md-12" allowmodifycontent="true">
<div class="">
<div>
<p style="line-height: 120%;" class=""><span style="font-size: 14px;">SENVELGO oral solution is the easy-to-give, once-daily liquid oral solution that makes treating feline diabetes more convenient for the owners of newly
diagnosed felines.</span></p>
<ul>
<li style="font-size: 14px; line-height: 120%;">Once-Daily Treatment</li>
<li style="font-size: 14px; line-height: 120%;" class="">Liquid Oral Administration</li>
<li style="font-size: 14px; line-height: 120%;" class="">No Refrigeration Needed</li>
</ul>
<p style="margin-bottom: 8px; line-height: 120%;" class=""><span style="font-size: 14px;">We invite you to experience SENVELGO yourself and see how you can help change the lives of feline diabetics. Please view the video above and
complete the following form to order your free sample.</span></p>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="height: 15px;" class=""></div>
</div>
</div>
<div id="block9a6f5da4-500c-457f-b0ef-f65809fbd343" class="block-wrapper">
<div>
<div class="container-fluid">
<div class="container" style="padding-top: 15px; padding-bottom: 0px;">
<div class="row gx-5">
<div class="col-md-12" allowmodifycontent="true">
<div class="mb-3" incontentsection="innerContent"><label for="atom48f23135-c8f3-48bb-b8f6-aeb3247c6800" class="form-label">Customer ID (Sold-To Number)</label><textarea placeholder="" id="atom48f23135-c8f3-48bb-b8f6-aeb3247c6800"
name="text_area" aria-describedby="helpatom48f23135-c8f3-48bb-b8f6-aeb3247c6800" required="" data-sync-data="true" class="form-control" style="height: 50px;"></textarea></div>
<div class="mb-3" incontentsection="innerContent"><label for="atome0303e79-6854-453f-89af-df4455baad79" class="form-label">First Name</label><input type="text" id="atome0303e79-6854-453f-89af-df4455baad79" required=""
aria-describedby="helpatome0303e79-6854-453f-89af-df4455baad79" placeholder="" name="text_input" data-sync-data="true" class="form-control"></div>
<div class="mb-3" incontentsection="innerContent"><label for="atom57f6d85d-4a72-4525-88a0-805a0b92fcdf" class="form-label">Last Name</label><textarea placeholder="" id="atom57f6d85d-4a72-4525-88a0-805a0b92fcdf" name="text_area"
aria-describedby="helpatom57f6d85d-4a72-4525-88a0-805a0b92fcdf" required="" data-sync-data="true" class="form-control" style="height: 50px;"></textarea></div>
<div class="mb-3" incontentsection="innerContent"><label for="atom0d9ba888-6586-47f8-8124-b883c637b3ad" class="form-label">Professional Email Address</label> <input placeholder="" id="atom0d9ba888-6586-47f8-8124-b883c637b3ad"
type="email" name="email" aria-describedby="helpatom0d9ba888-6586-47f8-8124-b883c637b3ad" required="" data-sync-data="true" class="form-control" style="height: 50px;"></div>
<div class="mb-3" incontentsection="innerContent"><label for="atomabb99364-e0d7-4559-81fd-4fef79c1d3b0" class="form-label">Practice ZIP</label><textarea placeholder="" id="atomabb99364-e0d7-4559-81fd-4fef79c1d3b0" name="text_area"
aria-describedby="helpatomabb99364-e0d7-4559-81fd-4fef79c1d3b0" required="" minlength="0" maxlength="500" data-sync-data="true" class="form-control" style="height: 50px;"></textarea></div>
<div class="">
<div>
<p style="line-height: 120%;" class=""><span style="font-size: 14px;">†By clicking "Submit," you are sharing your information to Boehringer Ingelheim Animal Health USA Inc., and you agree we may send you coupons, offers, and
information. To better understand our commitment to your privacy, please see our
<a href="https://docs.boehringer-ingelheim.com/Privacy%20Statements/BIPI%20Online%20Privacy%20Policy.htm" target="_blank" rel="noopener" data-it-button="CTA:Privacy Notice" class="">Privacy Notice</a>.</span></p>
</div>
</div>
<div class="gap-2 d-grid justify-content-center"><input type="submit" name="" data-it-button="CTA:SUBMIT" class="btn btn-primary form-submit-button" value="SUBMIT" id="input172483981743285"></div>
</div>
</div>
</div>
</div>
<div style="height: 15px;"></div>
</div>
</div>
<div id="blockac9aaec1-ed20-4931-8a65-fa81fe5eae29" class="block-wrapper">
<div>
<div class="container-fluid">
<div class="container" style="padding-top: 15px; padding-bottom: 0px;">
<div class="row gx-5">
<div class="col-md-12" allowmodifycontent="true">
<div class="">
<div class="">
<p style="line-height: 120%;" class=""><strong><span style="font-size: 14px;">IMPORTANT SAFETY INFORMATION:</span></strong></p>
<p style="line-height: 120%;"><span style="font-size: 14px;">SENVELGO<sup>®</sup> (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with
insulin. <strong>Before using this product, it is important to read the entire product insert, including the boxed warning. </strong></span></p>
<p style="line-height: 120%;" class=""><span style="font-size: 14px;"><strong>Cats treated with SENVELGO may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death.
Development of these conditions should be treated promptly, including insulin administration and discontinuation of SENVELGO. </strong></span></p>
<p style="line-height: 120%;"><span style="font-size: 14px;"><strong>Do not use SENVELGO in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent
diabetes mellitus.</strong> The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or
euglycemic diabetic ketoacidosis and death. </span></p>
<p style="line-height: 120%;" class=""><span style="font-size: 14px;">Sudden onset of hyporexia/anorexia, lethargy, dehydration, or weight loss in cats receiving SENVELGO should prompt immediate discontinuation of SENVELGO and
assessment for diabetic ketoacidosis, regardless of blood glucose level. SENVELGO should not be initiated in cats with etonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes
mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis. </span></p>
<p style="line-height: 120%;"><span style="font-size: 14px;">Keep SENVELGO in a secure location out of reach of children, dogs, cats, and other animals to avoid accidental ingestion or overdose. </span><strong><span
style="font-size: 14px;">For more information, please see full
<a href="https://docs.boehringer-ingelheim.com/SENVELGO_oral_solution_PI.pdf" data-it-button="CTA:prescribing information" target="_blank" rel="noopener">prescribing information</a>.</span></strong></p>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="height: 15px;" class=""></div>
</div>
</div>
<div></div>
<div id="block4eac06c4-bc45-48e4-b63e-a33f6fcc90e5" class="block-wrapper">
<div>
<div class="container-fluid footer" style="padding-top: 30px; padding-bottom: 15px;">
<div class="container">
<div class="row gx-5">
<div class="col-md-12" allowmodifycontent="true">
<div incontentsection="footer" class=""><img src="https://res.info.boehringer-ingelheim.ca/res/boehrin_mkt_prod1/70db2f8aa018e01a7f17f6797106e02a.svg" alt="" width="180" class="img-fluid d-block mx-auto mobile-width-100 nlui-widget">
</div>
<div role="presentation" class="spacer" incontentsection="footer" style="height: 20px;"></div>
<div class="">
<div>
<p class=""><a href="https://docs.boehringer-ingelheim.com/Terms%20and%20Conditions/Website%20Terms%20and%20Conditions" target="_blank" rel="noopener" data-it-button="Footer:Terms of Use">Terms of Use</a></p>
<p class=""><a href="https://docs.boehringer-ingelheim.com/Privacy%20Statements/BIPI%20Online%20Privacy%20Policy.htm" target="_blank" rel="noopener" data-it-button="Footer:Terms of Use">Privacy Policy</a></p>
<p class="">SENVELGO<sup>®</sup> and the SENVELGO Logo<sup>®</sup> are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under license. ©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights
reserved. US-PET-0536-2024</p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<input name="ctx" type="hidden"><input name="userAction" type="hidden"><input name="transition" type="hidden">
</form>Text Content
GET TO KNOW SENVELGO® (VELAGLIFLOZIN ORAL SOLUTION) SENVELGO oral solution is the easy-to-give, once-daily liquid oral solution that makes treating feline diabetes more convenient for the owners of newly diagnosed felines. * Once-Daily Treatment * Liquid Oral Administration * No Refrigeration Needed We invite you to experience SENVELGO yourself and see how you can help change the lives of feline diabetics. Please view the video above and complete the following form to order your free sample. Customer ID (Sold-To Number) First Name Last Name Professional Email Address Practice ZIP †By clicking "Submit," you are sharing your information to Boehringer Ingelheim Animal Health USA Inc., and you agree we may send you coupons, offers, and information. To better understand our commitment to your privacy, please see our Privacy Notice. IMPORTANT SAFETY INFORMATION: SENVELGO® (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. Before using this product, it is important to read the entire product insert, including the boxed warning. Cats treated with SENVELGO may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death. Development of these conditions should be treated promptly, including insulin administration and discontinuation of SENVELGO. Do not use SENVELGO in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death. Sudden onset of hyporexia/anorexia, lethargy, dehydration, or weight loss in cats receiving SENVELGO should prompt immediate discontinuation of SENVELGO and assessment for diabetic ketoacidosis, regardless of blood glucose level. SENVELGO should not be initiated in cats with etonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis. Keep SENVELGO in a secure location out of reach of children, dogs, cats, and other animals to avoid accidental ingestion or overdose. For more information, please see full prescribing information. Terms of Use Privacy Policy SENVELGO® and the SENVELGO Logo® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under license. ©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-PET-0536-2024